Pipethiaden is a benzothiepin-based drug candidate that was at one time studied as a potential preventive to reduce the frequency of recurrent migraine headaches. It also has some activity as an antihistamine acting mainly at the 5-HT2A and 5HT2C receptors.[2]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H19NS2 |
Molar mass | 313.48 g·mol−1 |
3D model (JSmol) | |
| |
References
edit- ^ "1-Methyl-4-(thieno[2,3-c][2]benzothiepin-4(9H)-ylidene)piperidine".
- ^ Frycová H, Metys J (July 1989). "[Anti-allergic properties of pipethiaden--a new preventive agent for migraine]". Ceskoslovenska Farmacie (in Czech). 38 (6): 264–8. PMID 2790993.